511 Episodes

  1. S14 Ep35: FDA Approval Insights: Y-90 Resin Microspheres for Unresectable HCC: With Armeen Mahvash, MD

    Published: 10/27/2025

  2. S14 Ep34: FDA Approval Insights: Adjuvant Cemiplimab for High-Risk CSCC: With Vishal A. Patel, MD, FAAD, FACMS

    Published: 10/23/2025

  3. S14 Ep33: Tumor Board: Advances in Managing EGFR-Mutant NSCLC: Applying Evidence Across the Disease Continuum

    Published: 10/23/2025

  4. S14 Ep32: Evolving Treatment Strategies and Novel Therapies Reshape Secondary AML Management: With Eunice Wang, MD

    Published: 10/22/2025

  5. S14 Ep31: Metastatic Breast Cancer 2025 UPDATE

    Published: 10/20/2025

  6. S14 Ep30: FDA Approval Insights: Subcutaneous Pembrolizumab for Solid Tumors: With J. Thaddeus Beck, MD, FACP

    Published: 10/16/2025

  7. S14 Ep29: Passion and Innovation Formed the Foundation for a Leading Cancer Program: With Girindra Raval, MD; and Anand Jillella, MD

    Published: 10/15/2025

  8. S14 Ep28: Oncology Experts Preview Key Studies Ahead of the 2025 ESMO Congress

    Published: 10/13/2025

  9. S14 Ep27: FDA Approval Insights: Gemcitabine Intravesical System for NMIBC: With Joseph Jacob, MD, MCR

    Published: 10/9/2025

  10. S14 Ep26: FDA Approval Insights: Sunvozertinib in EGFR-Mutated Metastatic NSCLC: With Lyudmila Bazhenova, MD

    Published: 10/8/2025

  11. S14 Ep25: Sequencing, Efficacy, and Safety Data May Further Evolve the Role of Fruquintinib in CRC: With Kanwal P. S. Raghav, MBBS, MD

    Published: 10/6/2025

  12. S14 Ep24: FDA Approval Insights: Maintenance Lurbinectedin Plus Atezolizumab for ES-SCLC: With Anne Chiang, MD, PhD; and Stephen Liu, MD

    Published: 10/2/2025

  13. S14 Ep23: Early Biomarker Testing Optimizes Tepotinib Use in NSCLC With MET Exon 14 Skipping Mutations: With Stephen Liu, MD

    Published: 10/1/2025

  14. S14 Ep22: Expanding JAK Inhibitor Use Offers Increased Treatment Options for Cytopenic Myelofibrosis: With Andrew Kuykendall, MD

    Published: 9/29/2025

  15. S14 Ep21: Early CAR T-Cell Therapy Data Highlight Therapeutic Potential and Emerging Challenges in GI Cancers: With Kohei Shitara, MD

    Published: 9/25/2025

  16. S14 Ep20: The Evolving Role of Noncovalent BTK Inhibition Informs CLL Treatment Selection: With Asad Dean, MD

    Published: 9/24/2025

  17. S14 Ep19: Zidesamtinib Is Associated With CNS Activity and Low Rates of Neurologic AEs in Pretreated ROS1+ NSCLC: With Alexander Drilon, MD

    Published: 9/18/2025

  18. S14 Ep18: Patient Characteristics and Disease Factors Guide the Use of Dostarlimab in Recurrent Endometrial Cancer: With Dana M. Chase, MD

    Published: 9/17/2025

  19. S14 Ep17: Expert Guidance on Frequently Asked Questions Regarding the Use of ADCs in TNBC

    Published: 9/16/2025

  20. S14 Ep16: Establishing the Rationale for ADC and ICI Combinations in TNBC

    Published: 9/16/2025

2 / 26